{
    "code": "02022722",
    "url": "http:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02022722",
    "time": "2015-08-24 12:59:43",
    "許可證字號": "衛署藥輸字第022722號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "108\/12\/31",
    "發證日期": "88\/12\/31",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00202272201",
    "中文品名": "帕森治錠５公絲",
    "英文品名": "SELGENE TABLETS 5MG",
    "適應症": "巴金森病症之輔助治療劑。",
    "劑型": "110錠劑",
    "包裝": "瓶裝",
    "藥品類別": "06須由醫師處方使用",
    "管制藥品分類級別": "",
    "主成分略述": "SELEGILINE HYDROCHLORIDE(DEPRENYL HYDROCHLORIDE)",
    "限制項目": [
        "02輸入"
    ],
    "申請商名稱": "1011101100  海喬國際股份有限公司",
    "申請商地址": "台北市大同區重慶北路三段276號9樓",
    "主製造廠": {
        "製造廠名稱": "F020003000  ALPHAPHARM PTY LTD.",
        "製造廠廠址": "102 ANTIMONY STREET CAROLE PARK, QLD 4300, AUSTRALIA",
        "製造廠公司地址": "15-25 GARNET STREET CAROLE PARK, QLD 4300, AUSTRALIA",
        "製造廠國別": "AUSTRALIA",
        "製程": ""
    },
    "CCC號列": "30049099904 其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses,put up in measured doses or in forms or packings for retail sale",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "2816401112",
            "成分名稱": "SELEGILINE HYDROCHLORIDE(DEPRENYL HYDROCHLORIDE)",
            "含量描述": "5",
            "含量": "5.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "020227220001.doc",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02022722&Seq=001&Type=9"
        }
    ]
}